DrugPatentWatch Database Preview
Elosulfase alfa - Biologic Drug Details
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
Summary for elosulfase alfa
| Tradenames: | 1 |
| Patents: | 1 |
| Applicants: | 1 |
| BLAs: | 1 |
| Suppliers: see list | 1 |
Pharmacology for elosulfase alfa
| Ingredient-type | alpha-Glucosidases |
Patent Text Search: US Patents for elosulfase alfa
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biomarin Pharm | VIMIZIM | elosulfase alfa | INJECTABLE;INJECTION | 125460 | 001 | 2014-02-14 | Start Trial | Corning Incorporated (Corning, NY) | 2031-10-25 | RX | Orphan | search |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
